Ami Batchelder

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

George B. McDonald, John T. Slattery, M Bouvier et al. · Blood · 2003 · 382 citations

Medicine, Hematology, Pharmacology +16

Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors

Sangeeta Hingorani, Katherine A. Guthrie, Ami Batchelder et al. · Kidney International · 2004 · 129 citations

Medicine, Hematology, Nephrology +15

Cyclophosphamide following Targeted Oral Busulfan as Conditioning for Hematopoietic Cell Transplantation: Pharmacokinetics, Liver Toxicity, and Mortality

Jeannine S. McCune, Ami Batchelder, H. Joachim Deeg et al. · Biology of Blood and Marrow Transplantation · 2007 · 97 citations · Full text

Pharmacy, Hematology, Pharmacokinetics +17

Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes

Andrew R. Rezvani, Jeannine S. McCune, Barry E. Storer et al. · Biology of Blood and Marrow Transplantation · 2013 · 82 citations · Full text

Medicine, Hematology, Pharmacokinetics +17

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Ami Batchelder, KA Guthrie, Robert P. Witherspoon et al. · Clinical Pharmacology & Therapeutics · 2009 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17